Back

VDD and DDD pacing following transcatheter aortic valve replacement: a three-year comparative echocardiographic follow-up

13 April 2026 (08:00 - 18:15)
Organised by: Logo
Congress Presentation Part of: Poster session (2): device therapy Antibradycardia Pacing EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Mario Giannotti Santoro

University Hospital of Pisa, Pisa (Italy)

210 More presentations in this session

Presentation thumbnail
Genetic variants and device upgrade in young pacemaker recipients
Doctor J. Sanchez Moreno (Almeria, ES)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic repolarization changes following conduction system pacing in pacemaker-induced cardiomyopathy
Doctor A. Sahin (Konya, TR)
Abstract Slides Video
Presentation thumbnail
Experiences with implantable loop recorders in syncope patients
Mr A. Oinonen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Forcecardiography as a non-invasive predictor of echocardiographic parameters in patients undergoing cardiac resynchronization therapy: a preliminary study
Doctor V. Pergola (Naples, IT)
Abstract
Presentation thumbnail
Diagnostic work-up and clinical characteristics in out-of-hospital cardiac arrest survivors with ICD implantation: a prospective Danish study
Mr C. Hansen (Copenhagen, DK) Doctor B. Winkel (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Poster session (2): device therapy

The Event

Event poster

EHRA 2026

13 April 2026 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Single lead atrioventricular sequential pacing after transcatheter aortic valve replacement: a safe and effective alternative to dual lead systems
thumbnail
Congress Presentation
Long-term outcomes of patients requiring pacemaker implantation after transcatheter aortic valve implantation: insights from the nationwide SwissTAVI registry
thumbnail
Congress Presentation
Long-term time-course of atrial sensing and incidence of atrial fibrillation in patients with VDD versus DDD pacemakers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources